Acute cardiac volume load-related changes in plasma atrial natriuretic peptide and N-terminal pro-B-type natriuretic peptide concentrations in healthy dogs

Veterinary Journal

Volumn 185, Issue 3, 2010, Pages 317-321

  Hori, Yasutomo ^a   Sano, Naoya ^a   Kanai, Kazutaka ^a   Hoshi, Fumio ^a   Itoh, Naoyuki ^a   Higuchi, Sei Ichi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Atrial natriuretic peptide (ANP); Canine; Cardiac preload; N terminal pro B type natriuretic peptide (NT proBNP); Pulmonary capillary wedge pressures

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ANIMAL EXPERIMENT; ARTICLE; DOG; ENZYME IMMUNOASSAY; FEMALE; HEART PRELOAD; HEART VENTRICLE OVERLOAD; HEART VOLUME; LUNG CAPILLARY PRESSURE; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; ANIMAL; BLOOD; HEALTH STATUS; HEMODYNAMICS; INTRAVENOUS DRUG ADMINISTRATION; LUNG WEDGE PRESSURE; PHYSIOLOGY; VETERINARY;

CANIS FAMILIARIS;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIAC VOLUME; DOGS; FEMALE; HEALTH STATUS; HEMODYNAMICS; INFUSIONS, INTRAVENOUS; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULMONARY WEDGE PRESSURE;

EID: 77955266465     PISSN: 10900233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tvjl.2009.06.008     Document Type: Article

References (33)

1. Asano K., Masuda K., Okumura M., Kadosawa T., Fujinaga T. Plasma atrial and brain natriuretic peptide levels in dogs with congestive heart failure. Journal of Veterinary Medical Science 1999, 61:523-529.
2. Asano K., Murakami M., Endo D., Kimura T., Fujinaga T. Complementary DNA cloning, tissue distribution and synthesis of canine brain natriuretic peptide. American Journal of Veterinary Research 1999, 60:860-864.
3. Berger R., Huelsmann M., Strecker K., Moertl D., Moser P., Bojic A., Pacher R. Neurohormonal risk stratification for sudden death and death owing to progressive heart failure in chronic heart failure. European Journal of Clinical Investigation 2005, 35:24-31.
4. Dzimiri N., Moorji A., Afrane B., Al-Halees Z. Differential regulation of atrial and brain natriuretic peptides and its implications for the management of left ventricular volume overload. European Journal of Clinical Investigation 2002, 32:563-569.
5. Frantz R.P., Olson L.J., Grill D., Moualla S.K., Nelson S.M., Nobrega T.P., Hanna R.D., Backes R.J., Mookadam F., Heublein D., Bailey K.R., Burnett J.C. Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failure. American Heart Journal 2005, 149:541-547.
6. Fung J.W., Yu C.M., Yip G., Chan S., Yandle T.G., Richards A.M., Nicholls M.G., Sanderson J.E. Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. American Journal of Cardiology 2003, 92:406-410.
7. Hara Y., Hamada M., Shigematsu Y., Suzuki M., Kodama K., Kuwahara T., Hashida H., Ikeda S., Ohtsuka T., Hiasa G., Hiwada K. Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor. Japanese Circulation Journal 2000, 64:365-369.
8. Hori Y., Tsubaki M., Katou A., Ono Y., Yonezawa T., Li X., Higuchi S.I. Evaluation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis. Journal of Veterinary Internal Medicine 2008, 22:1118-1123.
9. Hori Y., Ukai Y., Uechi M., Hoshi F., Higuchi S. Relationships between velocities of pulmonary venous flow and plasma concentrations of atrial natriuretic peptide in healthy dogs. American Journal of Veterinary Research 2008, 69:465-470.
10. Hori Y., Yamano S., Iwanaga K., Kano T., Tanabe M., Uechi M., Kanai K., Nakao R., Hoshi F., Higuchi S. Evaluation of plasma C-terminal atrial natriuretic peptide in healthy cats and cats with heart disease. Journal of Veterinary Internal Medicine 2008, 22:135-139.
11. Lang C.C., Choy A.M., Turner K., Tobin R., Coutie W., Struthers A.D. The effect of intravenous saline loading on plasma levels of brain natriuretic peptide in man. Journal of Hypertension 1993, 11:737-741.
12. Luchner A., Muders F., Dietl O., Friedrich E., Blumberg F., Protter A.A., Riegger G.A., Elsner D. Differential expression of cardiac ANP and BNP in a rabbit model of progressive left ventricular dysfunction. Cardiovascular Research 2001, 51:601-607.
13. Luchner A., Stevens T.L., Borgeson D.D., Redfield M., Wei C.M., Porter J.G., Burnett J.C. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. American Journal of Physiology 1998, 274:H1684-H1689.
14. Maczewski M., Mackiewicz U. Plasma brain natriuretic peptide correlates with infarct size but not with subsequent remodeling in the rat heart. Cardiovascular Pathology 2007, 16:79-84.
15. Maeda K., Tsutamoto T., Wada A., Mabuchi N., Hayashi M., Hisanaga T., Kamijo T., Kinoshita M. Insufficient secretion of atrial natriuretic peptide at acute phase of myocardial infarction. Journal of Applied Physiology 2000, 89:458-464.
16. Magga J., Vuolteenaho O., Tokola H., Marttila M., Ruskoaho H. Involvement of transcriptional and posttranscriptional mechanisms in cardiac overload-induced increase of B-type natriuretic peptide gene expression. Circulation Research 1997, 81:694-702.
17. Mangat H., de Bold A.J. Stretch-induced atrial natriuretic factor release utilizes a rapidly depleting pool of newly synthesized hormone. Endocrinology 1993, 133:1398-1403.
18. Matsumoto N., Akaike M., Nishiuchi T., Kawai H., Saito S. Different secretion profiles of atrial and brain natriuretic peptides after acute volume loading in patients with ischemic heart disease. Acta Cardiologica 1997, 52:261-272.
19. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., Tunstall-Pedoe H., McMurray J.J., Dargie H.J. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998, 351:9-13.
20. Moe G.W., Grima E.A., Wong N.L., Howard R.J., Armstrong P.W. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure. Journal of the American College of Cardiology 1996, 27:720-727.
21. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., Shirakami G., Jougasaki M., Obata K., Yasue H. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. Journal of Clinical Investigation 1991, 87:1402-1412.
22. Nagaya N., Nishikimi T., Uematsu M., Kyotani S., Satoh T., Nakanishi N., Matsuo H., Kangawa K. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect. American Heart Journal 1998, 136:297-301.
23. O'Sullivan M.L., O'Grady M.R., Minors S.L. Plasma big endothelin-1, atrial natriuretic peptide, aldosterone, and norepinephrine concentrations in normal Doberman Pinschers and Doberman Pinschers with dilated cardiomyopathy. Journal of Veterinary Internal Medicine 2007, 21:92-99.
24. Oyama M.A., Fox P.R., Rush J.E., Rozanski E.A., Lesser M. Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity. Journal of the American Veterinary Medical Association 2008, 232:1496-1503.
25. Oyama M.A., Sisson D.D., Solter P.F. Prospective screening for occult cardiomyopathy in dogs by measurement of plasma atrial natriuretic peptide, B-type natriuretic peptide, and cardiac troponin-I concentrations. American Journal of Veterinary Research 2007, 68:42-47.
26. Qi W., Kjekshus J., Hall C. Differential responses of plasma atrial and brain natriuretic peptides to acute alteration in atrial pressure in pigs. Scandinavian Journal of Clinical and Laboratory Investigation 2000, 60:55-63.
27. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocrine Reviews 2003, 24:341-356.
28. Seilhamer J.J., Arfsten A., Miller J.A., Lundquist P., Scarborough R.M., Lewicki J.A., Porter J.G. Human and canine gene homologs of porcine brain natriuretic peptide. Biochemical and Biophysical Research Communications 1989, 165:650-658.
29. Takemura N., Koyama H., Sako T., Ando K., Suzuki K., Motoyoshi S., Marumo F. Pharmacokinetics of human alpha-atrial natriuretic peptide (alpha-hANP) in cow and dog. Nippon Juigaku Zasshi 1990, 52:165-166.
30. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., Ohnishi M., Sugimoto Y., Kinoshita M. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997, 96:509-516.
31. Wambach G., Koch J. BNP plasma levels during acute volume expansion and chronic sodium loading in normal men. Clinical and Experimental Hypertension 1995, 17:619-629.
32. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., Ogawa H., Okumura K., Mukoyama M., Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994, 90:195-203.
33. Yoshimura M., Yasue H., Okumura K., Ogawa H., Jougasaki M., Mukoyama M., Nakao K., Imura H. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 1993, 87:464-469.